+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Device Combination Products - Global Market Trajectory & Analytics

  • ID: 5140338
  • Report
  • September 2020
  • Region: Global
  • 202 pages
  • Global Industry Analysts, Inc
Global Drug Device Combination Products Market to Reach $133.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Drug Device Combination Products estimated at US$90.3 Billion in the year 2020, is projected to reach a revised size of US$133.3 Billion by 2027, growing at a CAGR of 5.7% over the analysis period 2020-2027. Drug Eluting Stents, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$14 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Infusion Pumps segment is readjusted to a revised 5.6% CAGR for the next 7-year period.

The U. S. Market is Estimated at $24.4 Billion, While China is Forecast to Grow at 8.8% CAGR

The Drug Device Combination Products market in the U. S. is estimated at US$24.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$28.1 Billion by the year 2027 trailing a CAGR of 8.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Photodynamic Therapy Segment to Record 5.1% CAGR

In the global Photodynamic Therapy segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2 Billion in the year 2020 will reach a projected size of US$2.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$17.9 Billion by the year 2027, while Latin America will expand at a 6.1% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 202-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Abbott Laboratories
  • Alcon, a Novartis Company
  • Allergan PLC
  • Arrow International, Inc.
  • Bausch & Lomb, Inc.
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • CareFusion Corporation
  • Ethicon US LLC
  • Medline Industries, Inc.
  • Medtronic PLC
  • Mylan NV
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
Note: Product cover images may vary from those shown
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Global Competitor Market Shares
  • Drug Device Combination Products Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: Drug Device Combination Products Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Drug Device Combination Products Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Drug Device Combination Products Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Drug Eluting Stents (Segment) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: Drug Eluting Stents (Segment) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: Drug Eluting Stents (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Infusion Pumps (Segment) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Infusion Pumps (Segment) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: Infusion Pumps (Segment) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Photodynamic Therapy (Segment) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: Photodynamic Therapy (Segment) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Photodynamic Therapy (Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Prefilled Syringes (Segment) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: Prefilled Syringes (Segment) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 15: Prefilled Syringes (Segment) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Antimicrobial Wound Dressings (Segment) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 17: Antimicrobial Wound Dressings (Segment) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 18: Antimicrobial Wound Dressings (Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Inhalers (Segment) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
  • TABLE 20: Inhalers (Segment) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 21: Inhalers (Segment) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 22: Transdermal Patches (Segment) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
  • TABLE 23: Transdermal Patches (Segment) Global Historic Demand in US$ Million by Region/Country: 2012 to 2019
  • TABLE 24: Transdermal Patches (Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 25: Other Drug Device Combination Products (Segment) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 26: Other Drug Device Combination Products (Segment) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 27: Other Drug Device Combination Products (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Drug Device Combination Products Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • TABLE 28: United States Drug Device Combination Products Market Estimates and Projections in US$ Million by Segment: 2020 to 2027
  • TABLE 29: Drug Device Combination Products Market in the United States by Segment: A Historic Review in US$ Million for 2012-2019
  • TABLE 30: United States Drug Device Combination Products Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
CANADA
  • TABLE 31: Canadian Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2020 to 2027
  • TABLE 32: Canadian Drug Device Combination Products Historic Market Review by Segment in US$ Million: 2012-2019
  • TABLE 33: Drug Device Combination Products Market in Canada: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027
JAPAN
  • TABLE 34: Japanese Market for Drug Device Combination Products: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2020-2027
  • TABLE 35: Drug Device Combination Products Market in Japan: Historic Sales Analysis in US$ Million by Segment for the Period 2012-2019
  • TABLE 36: Japanese Drug Device Combination Products Market Share Analysis by Segment: 2012 VS 2020 VS 2027
CHINA
  • TABLE 37: Chinese Drug Device Combination Products Market Growth Prospects in US$ Million by Segment for the Period 2020-2027
  • TABLE 38: Drug Device Combination Products Historic Market Analysis in China in US$ Million by Segment: 2012-2019
  • TABLE 39: Chinese Drug Device Combination Products Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
EUROPE
  • Market Facts & Figures
  • European Drug Device Combination Products Market: Competitor Market ShareScenario (in %) for 2019 & 2025
  • Market Analytics
  • TABLE 40: European Drug Device Combination Products Market Demand Scenario in US$ Million by Region/Country: 2020-2027
  • TABLE 41: Drug Device Combination Products Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 42: European Drug Device Combination Products Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 43: European Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2020-2027
  • TABLE 44: Drug Device Combination Products Market in Europe in US$ Million by Segment: A Historic Review for the Period 2012-2019
  • TABLE 45: European Drug Device Combination Products Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
FRANCE
  • TABLE 46: Drug Device Combination Products Market in France by Segment: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 47: French Drug Device Combination Products Historic Market Scenario in US$ Million by Segment: 2012-2019
  • TABLE 48: French Drug Device Combination Products Market Share Analysis by Segment: 2012 VS 2020 VS 2027
GERMANY
  • TABLE 49: Drug Device Combination Products Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2020-2027
  • TABLE 50: German Drug Device Combination Products Historic Market Analysis in US$ Million by Segment: 2012-2019
  • TABLE 51: German Drug Device Combination Products Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
ITALY
  • TABLE 52: Italian Drug Device Combination Products Market Growth Prospects in US$ Million by Segment for the Period 2020-2027
  • TABLE 53: Drug Device Combination Products Historic Market Analysis in Italy in US$ Million by Segment: 2012-2019
  • TABLE 54: Italian Drug Device Combination Products Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED KINGDOM
  • TABLE 55: United Kingdom Market for Drug Device Combination Products: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2020-2027
  • TABLE 56: Drug Device Combination Products Market in the United Kingdom: Historic Sales Analysis in US$ Million by Segment for the Period 2012-2019
  • TABLE 57: United Kingdom Drug Device Combination Products Market Share Analysis by Segment: 2012 VS 2020 VS 2027
SPAIN
  • TABLE 58: Spanish Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2020 to 2027
  • TABLE 59: Spanish Drug Device Combination Products Historic Market Review by Segment in US$ Million: 2012-2019
  • TABLE 60: Drug Device Combination Products Market in Spain: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027
RUSSIA
  • TABLE 61: Russian Drug Device Combination Products Market Estimates and Projections in US$ Million by Segment: 2020 to 2027
  • TABLE 62: Drug Device Combination Products Market in Russia by Segment: A Historic Review in US$ Million for 2012-2019
  • TABLE 63: Russian Drug Device Combination Products Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
REST OF EUROPE
  • TABLE 64: Rest of Europe Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2020-2027
  • TABLE 65: Drug Device Combination Products Market in Rest of Europe in US$ Million by Segment: A Historic Review for the Period 2012-2019
  • TABLE 66: Rest of Europe Drug Device Combination Products Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
ASIA-PACIFIC
  • TABLE 67: Asia-Pacific Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 68: Drug Device Combination Products Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 69: Asia-Pacific Drug Device Combination Products Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 70: Drug Device Combination Products Market in Asia-Pacific by Segment: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 71: Asia-Pacific Drug Device Combination Products Historic Market Scenario in US$ Million by Segment: 2012-2019
  • TABLE 72: Asia-Pacific Drug Device Combination Products Market Share Analysis by Segment: 2012 VS 2020 VS 2027
AUSTRALIA
  • TABLE 73: Drug Device Combination Products Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2020-2027
  • TABLE 74: Australian Drug Device Combination Products Historic Market Analysis in US$ Million by Segment: 2012-2019
  • TABLE 75: Australian Drug Device Combination Products Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
INDIA
  • TABLE 76: Indian Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2020 to 2027
  • TABLE 77: Indian Drug Device Combination Products Historic Market Review by Segment in US$ Million: 2012-2019
  • TABLE 78: Drug Device Combination Products Market in India: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027
SOUTH KOREA
  • TABLE 79: Drug Device Combination Products Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2020-2027
  • TABLE 80: South Korean Drug Device Combination Products Historic Market Analysis in US$ Million by Segment: 2012-2019
  • TABLE 81: Drug Device Combination Products Market Share Distribution in South Korea by Segment: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
  • TABLE 82: Rest of Asia-Pacific Market for Drug Device Combination Products: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2020-2027
  • TABLE 83: Drug Device Combination Products Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Segment for the Period 2012-2019
  • TABLE 84: Rest of Asia-Pacific Drug Device Combination Products Market Share Analysis by Segment: 2012 VS 2020 VS 2027
LATIN AMERICA
  • TABLE 85: Latin American Drug Device Combination Products Market Trends by Region/Country in US$ Million: 2020-2027
  • TABLE 86: Drug Device Combination Products Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
  • TABLE 87: Latin American Drug Device Combination Products Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
  • TABLE 88: Latin American Drug Device Combination Products Market Growth Prospects in US$ Million by Segment for the Period 2020-2027
  • TABLE 89: Drug Device Combination Products Historic Market Analysis in Latin America in US$ Million by Segment: 2012-2019
  • TABLE 90: Latin American Drug Device Combination Products Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
ARGENTINA
  • TABLE 91: Argentinean Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2020-2027
  • TABLE 92: Drug Device Combination Products Market in Argentina in US$ Million by Segment: A Historic Review for the Period 2012-2019
  • TABLE 93: Argentinean Drug Device Combination Products Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
BRAZIL
  • TABLE 94: Drug Device Combination Products Market in Brazil by Segment: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 95: Brazilian Drug Device Combination Products Historic Market Scenario in US$ Million by Segment: 2012-2019
  • TABLE 96: Brazilian Drug Device Combination Products Market Share Analysis by Segment: 2012 VS 2020 VS 2027
MEXICO
  • TABLE 97: Drug Device Combination Products Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2020-2027
  • TABLE 98: Mexican Drug Device Combination Products Historic Market Analysis in US$ Million by Segment: 2012-2019
  • TABLE 99: Mexican Drug Device Combination Products Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
  • TABLE 100: Rest of Latin America Drug Device Combination Products Market Estimates and Projections in US$ Million by Segment: 2020 to 2027
  • TABLE 101: Drug Device Combination Products Market in Rest of Latin America by Segment: A Historic Review in US$ Million for 2012-2019
  • TABLE 102: Rest of Latin America Drug Device Combination Products Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
MIDDLE EAST
  • TABLE 103: The Middle East Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 104: Drug Device Combination Products Market in the Middle East by Region/Country in US$ Million: 2012-2019
  • TABLE 105: The Middle East Drug Device Combination Products Market Share Breakdown by Region/Country: 2012, 2020, and 2027
  • TABLE 106: The Middle East Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2020 to 2027
  • TABLE 107: The Middle East Drug Device Combination Products Historic Market by Segment in US$ Million: 2012-2019
  • TABLE 108: Drug Device Combination Products Market in the Middle East: Percentage Share Breakdown of Sales by Segment for 2012,2020, and 2027
IRAN
  • TABLE 109: Iranian Market for Drug Device Combination Products: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2020-2027
  • TABLE 110: Drug Device Combination Products Market in Iran: Historic Sales Analysis in US$ Million by Segment for the Period 2012-2019
  • TABLE 111: Iranian Drug Device Combination Products Market Share Analysis by Segment: 2012 VS 2020 VS 2027
ISRAEL
  • TABLE 112: Israeli Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2020-2027
  • TABLE 113: Drug Device Combination Products Market in Israel in US$ Million by Segment: A Historic Review for the Period 2012-2019
  • TABLE 114: Israeli Drug Device Combination Products Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
SAUDI ARABIA
  • TABLE 115: Saudi Arabian Drug Device Combination Products Market Growth Prospects in US$ Million by Segment for the Period 2020-2027
  • TABLE 116: Drug Device Combination Products Historic Market Analysis in Saudi Arabia in US$ Million by Segment: 2012-2019
  • TABLE 117: Saudi Arabian Drug Device Combination Products Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED ARAB EMIRATES
  • TABLE 118: Drug Device Combination Products Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2020-2027
  • TABLE 119: United Arab Emirates Drug Device Combination Products Historic Market Analysis in US$ Million by Segment: 2012-2019
  • TABLE 120: Drug Device Combination Products Market Share Distribution in United Arab Emirates by Segment: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
  • TABLE 121: Drug Device Combination Products Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2020-2027
  • TABLE 122: Rest of Middle East Drug Device Combination Products Historic Market Analysis in US$ Million by Segment: 2012-2019
  • TABLE 123: Rest of Middle East Drug Device Combination Products Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
AFRICA
  • TABLE 124: African Drug Device Combination Products Market Estimates and Projections in US$ Million by Segment: 2020 to 2027
  • TABLE 125: Drug Device Combination Products Market in Africa by Segment: A Historic Review in US$ Million for 2012-2019
  • TABLE 126: African Drug Device Combination Products Market Share Breakdown by Segment: 2012 VS 2020 VS 2027
IV. COMPETITION
  • Total Companies Profiled: 46
Note: Product cover images may vary from those shown
Adroll
adroll